Home  >  Products  >  GIPR (gastric inhibitory polypeptide receptor ) Blocking Peptide (the N terminal of GIPR)(100ug)
GIPR (gastric inhibitory polypeptide receptor ) Blocking Peptide (the N terminal of GIPR)(100ug)

GIPR (gastric inhibitory polypeptide receptor ) Blocking Peptide (the N terminal of GIPR)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GIPR Antibody (ARP63933_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63933
Size: 100ug
Weight: 53kDa
Gene: 2696
Format: Lyophilized powder
Target: This gene encodes a G-protein coupled receptor for gastric inhibitory polypeptide (GIP), which was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate insulin release in the presence of elevated glucose. Mice lacking this gene exhibit higher blood glucose levels with impaired initial insulin response after oral glucose load. Defect in this gene thus may contribute to the pathogenesis of diabetes.
Alternative names: MGC126722